Communications publiées lors de congrès ou colloques nationaux et internationaux (118)
  1. 112. Van Lint, C., Ghysdael, J., Paras, P., Burny, A., & Verdin, E. (1993). Several DNA-binding proteins bind to the intragenic enhancer located in the pol gene of HIV-1. Abstract of the 5th International Conference of the NCDDG-HIV: coordinated therapies for HIV infection (11-16 July, 1993: Georgetown University)
  2. 113. Verdin, E., Paras, P., El Kharroubi, A., & Van Lint, C. (1993). HIV-1 promoter activation is accompanied by the disruption of a nucleosome in the TAR region. Abstract of the 5th International Conference of the NCDDG-HIV: coordinated therapies for HIV infection (11-16 July, 1993: Georgetown University, Washington DC, USA)
  3. 114. Van Lint, C., Ghysdael, J., Paras, P., Burny, A., & Verdin, E. (1993). A transcriptional regulatory region is associated with a nuclease hypersensitive site in the pol gene of HIV-1 in a promonocytic cell line. Abstract of the 4th Rhine-Main Symposium on HIV and macrophages: functions of macrophages and accessory cells in HIV and other lentivirus infections. (13-15 Octobre 1993: Strasbourg, France)
  4. 115. Van Lint, C., Ghysdael, J., Paras, P., Burny, A., & Verdin, E. (1993). A T-lymphoid- and monocyte/macrophage transcriptional enhancer is associated with a DNase I hypersensitive site in the pol gene of HIV-1. Abstract of the 1993 Cold Spring Harbor Laboratory: Retroviruses Meeting (25-30 May 1993: New York, USA)
  5. 116. Verdin, E., Paras, P., El Kharroubi, A., & Van Lint, C. (1993). In vivo footprinting of the HIV-1 LTR identifies a chromatin disruption associated with promoter activation. Abstract of the 1993 Cold Spring Harbor Laboratory: Retroviruses Meeting (25-30 May 1993: New York, USA)
  6. 117. Verdin, E., Becker, N. G., Van Lint, C., & Burny, A. (1990). Identification and characterization of a transcriptional enhancer in the pol gene of HIV-1. Abstract of the 1990 Cold Spring Harbor Laboratory: RNA Tumor Viruses Meeting Cold Spring Harbor Laboratory: RNA Tumor Viruses Meeting.(23-27 May 1990: New York)
  7. 118. Verdin, E., Van Lint, C., & Burny, A. (1990). The intragenic enhancer of HIV-1 contains functional AP-1 binding sites. Abstract of the 1990 Annual Meeting of the NIH Laboratory of Tumor Cell Biology of the National Cancer Institute (11-17 August 1990: Bethesda, Maryland, USA)
    8.   Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (3)
  8. 1. Brenner, C., Coutte, L., Van Lint, C., Dolle, V., De Launoit, Y., & Baert, J.-L. (2016). The Ets transcription factor ERM interacts with the coactivators CBP/p300 to enhance transcription.
  9. 2. Burny, A., Badran, B., Bex, F., Kettmann, R., Willems, L., Portetelle, D., Van Lint, C., Vandenbol, M., Vandenbroeke, A., Willard-Gallo, K., & Zagury, D. (2003). Les cancers du poumon en 2003: vers des jours meilleurs.
  10. 3. Burny, A., Bex, F., & Van Lint, C. (1996). Aids science: A field in the S phase. Cellular pharmacology, 3 , 261-262.
    11.   Participations à des congrès et colloques internationaux (123)
  11. 1. Van Lint, C. (2024). Epigenetic and transcriptional mechanisms of HIV-1 latency: implications for innovative therapeutic strategies. Paper session presented at Seminar on invitation (December 18th 2024: Institut de Génétique Humaine, Montpellier, France).
  12. 2. Dutilleul, A., Bendoumou, M., Nestola, L., Paiardini, M., Kulpa, D., & Van Lint, C. (2024). Characterization of the molecular mechanisms involved in the HIV-1 pro-latency activity mediated by CD8+ T-lymphocytes. Paper session presented at The 11th international workshop on HIV persistence during therapy - Reservoirs & Eradication strategies workshop (10 - 13 December 2024: Fort-Lauderdale (Florida, USA)).
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 Suivant >>